#Germany #innoscripta SE #Clusterix #IRS documentation #Tutizng

Innoscripta SE Expands into the US Market

Innoscripta SE, a leading player in the field of research and development (R&D) software, has successfully made its mark on the US market in a short span of time. Just a few months after launching there, the company has attracted several high-profile clients who are now leveraging the Clusterix platform. This successful market entry aligns with Innoscripta's broader strategy to expand its international footprint, building on recent expansions into France and the United Kingdom.

The Rise of R&D Investment in the US

The US, recognized as the world's largest R&D market, plays a pivotal role in global innovation. In 2025 alone, analysis from EY revealed that the 140 top US companies invested approximately EUR 576 billion in R&D, marking an 11% increase from the previous year. This investment represents about 3.4% of the nation's GDP, underscoring the critical importance of R&D in the American economy.

As companies continue to innovate, there is an increasing scrutiny regarding how these R&D activities are documented, particularly in light of new IRS regulations. The IRS has tightened documentation requirements for qualified research expenditures, necessitating more granular disclosures under Form 6765, specifically Section G. This change has created a significant demand for solutions that facilitate comprehensive documentation of R&D activities.

How Clusterix Addresses New IRS Requirements

Innoscripta's Clusterix software platform has emerged as a crucial tool for US companies navigating these heightened documentation demands. By providing a structured and transparent way to document R&D projects, Clusterix ensures that businesses can meet the stringent requirements set forth by the IRS. This feature is particularly appealing to organizations looking to qualify for tax incentive programs not only in the US but also across multiple countries including Germany, the Netherlands, and Portugal.

Among the first clients of Innoscripta in the US is a notable international technology group based in New York, specializing in security and communications technology. This forward-thinking company is using Clusterix to enhance the management of its R&D documentation and optimize its tax-related incentives. Another client includes a Minnesota-based provider of clinical trial software, showcasing the versatility of Clusterix across different industries.

Innoscripta's Vision for the Future

As Innoscripta SE continues to grow its customer base in the US, the company is focused on significantly increasing its share of international revenues. The goal is to not only secure a solid footing in the American market but also to utilize lessons learned there as a launchpad for further international expansion. By continuing to innovate and adapt its offerings, Innoscripta aims to strengthen its position as a leader in R&D software solutions.

In conclusion, Innoscripta SE's successful entry into the US market exemplifies the company’s commitment to driving innovation and facilitating better management of R&D processes for businesses. As R&D requirements evolve, Innoscripta is poised to be a key player in helping organizations meet these challenges head-on, ensuring continued investment in technology and innovation across the globe.

For more information about Innoscripta and its innovative solutions, visit their official website or contact their press office directly.